Mural Oncology Plc
(MURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -46,467 | -189,807 | -141,225 |
| Depreciation Amortization | 530 | 1,540 | 1,043 |
| Other Working Capital | -12,553 | 7,748 | 746 |
| Other Operating Activity | 2,753 | 11,931 | 8,734 |
| Operating Cash Flow | $-55,737 | $-168,588 | $-130,702 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -398 | -5,511 | -5,368 |
| Investing Cash Flow | $-398 | $-5,511 | $-5,368 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 56,135 | 174,099 | 136,070 |
| Financing Cash Flow | $56,135 | $174,099 | $136,070 |
| Net Cash Flow | $N/A | $0 | $0 |
| Free Cash Flow | |||
| Operating Cash Flow | -55,737 | -168,588 | -130,702 |
| Capital Expenditure | -398 | N/A | -5,368 |
| Free Cash Flow | -56,135 | -168,588 | -136,070 |